NurExone Biologic Inc.: NurExone to Host Investor Webinar on Thursday, July 14, 2022
Bnei-Brak, Israel--(Newsfile Corp. - July 7, 2022) - NurExone Biologic Inc. (TSXV: NRX) ("NurExone" or the "Company"), a leading pharmaceutical company that develops innovative exosome-based treatments
United States Lior Shaltiel Nurexone Biologic Inc Israel Newsfile Corp Israel Institute Of Technology Regulation Services Provider
Source: finanznachrichten.de